amelogenesis imperfecta phenotype in AMI rats. We observed morphological changes of ameloblasts in Ami/Ami and Wt/Ami incisors (5) . However, the underlying mechanism through which Sp6 mutations lead to abnormal morphology remains unclear. Concurrently, we investigated the downstream targets of Sp6 using comparative microarray analyses and found that Rock1 is upregulated in the presence of the Sp6 protein (6) .
ROCK1 (Rho-associated coiled-coil-forming kinase 1) is a serine/threonine kinase which is activated by the small GTP-binding protein RhoA. There are two isoforms, ROCK1 and ROCK2, which share 65% identity in their complete amino acid sequences and 92% identity in their kinase domains (7) . However, the previous study showed distinct roles of ROCK isoforms in the same cells. ROCK1 activity is essential for formation of stress fibers and focal adhesion, on the other hand, ROCK2 acts as a counterbalancing regulator of microfilament bundle and focal adhesion sites (8) .
During tooth development, ROCK contributes to the polarity, proliferation, and differentiation of ameloblasts by regulating actin cytoskeleton organization and cell-cell adhesion (9) . RhoA also regulates the expression of amelogenin and DSPP during cytodifferentiation of ameloblasts and odontoblasts, respectively (10) . However, the regulation of Rock1 expression has not been investigated, although the activators of Rock1 have been widely discussed.
In the present study, we demonstrated that Sp6 positively regulates Rock1 expression by direct binding to the Rock1 promoter. We also observed the critical elements to affect both Sp6-enhanced Rock1 promoter activity and Sp6 binding to the Rock1 promoter. In addition, we found that Sp1 downregulated Rock1 transcription. The present data suggest a unique role of Sp6 in tooth development and morphogenesis that may be essential for future studies of tooth regeneration.
MATERIALS AND METHODS

Cell Culture
Rat dental epithelia-derived cells, G5 (11) and its Sp6-stable transformant, C9 (3), were cultured in a Dulbecco's modified Eagle's medium and Ham's F12 medium (D/F12, Nissui, Tokyo, Japan) supplemented with 10% fetal bovine serum (FBS ; JRH Biosciences, Lenexa, KS, USA) incubated at 37! ! in 5% CO2.
RNA Ligase-Mediated 5 ! -Rapid Amplification of cDNA Ends (RLM-RACE)
Total RNA was extracted from molars of 7-dayold stroke-prone spontaneously hypertensive rats (SHRSP) (5) using the TRI reagent (MRC, Cincinnati, OH, USA). RNA was then used in RLM-RACE assays with a GeneRacer kit (Invitrogen, Carlsbad, CA, USA), according to the manufacturer's protocol. In brief, total RNA was dephosphorylated with calf intestinal alkaline phosphatase followed by tobacco acid pyrophosphatase treatment to remove cap structures from the 5 ! ends of full-length mRNAs. Oligo RNAs were then added to the 5 ! ends of the RNA using RNA ligase. Ligated RNAs were reverse transcribed to cDNAs using oligo dT-primers, and these cDNAs were then used as templates in PCR amplification. Initial and nested PCRs were performed using the antisense primers 5 ! -GGGATCC-CGCAGCAGGTTGTCGA-3 ! and 5 ! -CAAGTTCAA-CCAACTTCCTCCGCGG-3 ! , respectively. Amplified products were subcloned into pGEM-T easy plasmid vectors (Promega, Madison, WI, USA), and eleven clones were sequenced.
In Silico Promoter Analysis
Potential transcription factor binding sites were identified in the 2500-bp region upstream to the newly identified transcription start site of Rock1 (accession number : AB861944) using the TFBIND algorithm (http : //tfbind.hgc.jp/). These sites were confirmed using the GENETYX software program, version 10 (Genetyx), and overlapping sites that were identified in the "A" region were used in further analyses.
Chromatin Immunoprecipitation (ChIP)-PCR assay
Sp6 binding to the Rock1 promoter in C9 cells were determined using a ChIP-IT Express Enzymatic kit (Active Motif, Carlsbad, CA, USA) with some modifications. In brief, cells were cross-linked with 1% formaldehyde for 10 min, harvested on ice, and were Dounce-homogenized 40 times in ice bath. DNA-protein complexes were enzymatically digested to the lengths of 200-1000 bp, as determined by gel electrophoresis. Rabbit IgG antiserum directed against anti-HA high affinity clone 3F10 (Roche, Mannheim, Germany) was used (3 μg of antisera per sample) to direct chromatin antibody pull-down at 4! !overnight in a rotary mixer (NRC-20D ; Nissin, Tokyo, Japan). Immunoprecipitated chromatin was treated sequentially with elution buffer, reverse cross-linking buffer, and proteinase K to recover DNA. The primer sequences and PCR conditions used to amplify chromatin DNA are presented in Table 1 . ChIP assays were performed in G5 cells cotransfected with pCI-neo mammalian expression vector (Promega) harboring HA-tagged rat Sp6 (WT) and pGL3-mutant reporter constructs. DNA was amplified using forward primers containing the mutant sequences (in bold) 1 (5 " -CCTGT-CCTCCACTAAATTTAAT-3 " ), 2 (5 " -TCCGACTT-CTCTTAAACCGAA-3 " ), 3 (5 " -CGCCCTCCGCC-TATAAGAAT-3 " ), and 4 (5 " -GCCTGCCAGGCCC-AATAAT-3 " ) and the reverse primer 5 " -TCCTGT-TCAAACAAACGGGG-3 " . PCR reactions were performed with 33 cycles of denaturing at 95! !for 45 s, annealing at 57! !for 45 s, and extension at 72! ! for 20 s.
Plasmid Constructs
Rat genomic DNA template was amplified by PCR using a PrimeSTAR Max Premix (Takara, Shiga, Japan) with the forward primer 5 " -TGGGCACATG-TTTTCCCATCTGTGGT-3 " and the reverse primer 5 " -TCTAAGGCGCTAGCGGCTGTCTAGC-3 " , which flanked the Rock1 region (from -2709 to +383). PCR reactions were performed with 20 cycles of denaturing at 98! !for 10 s, annealing at 55! !for 5 s, and extension at 72! ! for 15 s. Nested PCRs were performed to generate Rock1 promoter 5 " deletion constructs using the reverse primer 5 " -CCGA-AGCTTTTATCCGGTCGCTGCTGGGGTTACG-3 " and the forward primers Luc#1 5 " -CTAGAGCTC-GTCTGAAGAGTTGTGCCTAGCCCTTG-3 " , Luc#2 5 " -CTAGAGCTCTGACCTATGATGAAACCCAAG-GGTTGAT-3 " , Luc#3 5 " -CTAGAGCTCCCAGCTC-AGCCACCAGAGGCTGG-3 " , and Luc#4 5 " -CTAG-AGCTCAGGCGGACATATTAGTCCCTCTGAGC-3 " , which yielded varying PCR product lengths. PCR reactions were performed with 30 cycles of denaturing at 98! !for 10 s, annealing at 55! !for 5 s, and extension at 72! !for 15 s. For further 5 " deletion constructs in region "A", we used the forward primers Luc#3.1 5 " -CTAGAGCTCTCCTCC-ACTGGGTTTCCGACTTCTC-3 " , Luc#3.2 5 " -CTA-GAGCTCTCCGGCTCCGCCTCTCTCCCCTCC-3 " , Luc#3.3 5 " -CTAGAGCTCTCGCGACCCGGCCAG-CCCCGC-3 " , Luc#3.4 5 " -CTAGAGCTCCTGCGTG-CGCGTGCGCGAGCGCG-3 " , and Luc#3.5 5 " -CT-AGAGCTCGCGCGCCGGCGGTCCCCGTTTG-3 " , which yielded varying amplicon lengths. PCR reactions were performed with 30 cycles of denaturing at 98! !for 10 s, annealing at 55! !for 5 s, and extension at 72! !for 5 s. Additional SacI and HindIII restriction sites were incorporated into forward and reverse primers, respectively, to facilitate subcloning of amplified fragments. The PCR fragments and the luciferase reporter vector pGL3-basic were separately digested with SacI and HindIII before ligation, and reporter constructs were sequenced. Sp6 expression vector was described previously (3) . Sp1 expression vector was constructed using pCIneo mammalian expression vector (Promega). In brief, the entire rat Sp1 coding region was generated by RT-PCR using PrimeSTAR GXL DNA Polymerase (Takara) from total RNA of C9 cells (3) . FLAG-tag was added at the N-terminus of Sp1 cDNA in the forward primer. The primer sequences are the follows ; Forward, 5 " -CCACCA-TGGACTACAAAGACGATGACGACAAGAGCGA-CCAAGATCACTCAATGGATG-3 " (the underlined region indicates the position of the FLAG-tag sequence) ; Reverse, 5 " -ATCTCAGAAACATTGCCA-CTGATATTAATG-3 " .
Site-Directed Mutagenesis
Constructs containing mutant SP1 and AP2 sites from the Rock1 promoter region ranging from -206 to -150 were prepared using an AMAP Multi Site-Directed Mutagenesis kit (MBL, Woburn, MA, USA), according to the manufacturer's protocol. Luc#3 reporter plasmids were used as PCR templates, and the products were ligated using phosphorylated 
Transient Transfection and Dual Luciferase Reporter Assay
G5 cells were plated at 6.0!10 4 cells/well in 24-well plates one day before transfection. Cells were cotransfected with 400 ng of the pGL3-reporters pRock1-Luc or pRock1-Luc-Mut, 40 ng of pSP6 or pSP1, and 4 ng of the renilla luciferase reporter plasmid pRL-TK using the X-tremeGENE HP DNA Transfection Reagent (Roche), according to the manufacturer's instructions. After 24 h, cell lysates were prepared, according to the manufacturer's protocol, for the Dual Luciferase Reporter Assay System (Promega), and both firefly and renilla luciferase activities were measured using a Lumat LB 9507 (Berthold, Bad Wildbad, Germany). For the DNA binding inhibitory analysis by mithramycin A, the cells were cultured with a vehicle (DMSO) or varying doses of mithramycin A (Sigma, Tokyo, Japan) 5 h after transfection. The transient transfection and dual luciferase reporter assay were repeated at least two times in triplicates. The promoter activity of each Rock1 promoter construct was measured by luciferase activity and was normalized by that of the longest promoter construct without any mutation. For the analysis of the effect of Sp6 on Rock1 promoter activity, the activity was analyzed by comparing the luciferase activity of each promoter construct in Sp6-cotransfected sample with that of the same construct in pCIneo-cotransfected sample. For mithramycin A treatment, DMSO was used as control. The average of control samples is indicated as 100.
Reverse Transcription-PCR (RT-PCR)
G5 cells were plated at 2.88!10 5 cells/well in sixwell plates. The cells were transiently transfected with the empty pCI-neo, Sp6, or Sp1 expression vectors and were harvested after 24 h. Total RNA was extracted using the TRI reagent (MRC), according to the manufacturer's instructions. RNA was reversed transcribed using an RNA PCR kit AMV Ver. 3.0 (Takara), according to the manufacturer's instructions. Synthesized cDNA was analyzed by PCR using GoTaq DNA polymerase (Promega) with the forward primer 5 # -GGATGCTACCTGATCACC-AG-3 # and the reverse primer 5 # -CCGTAGGCAA-ACCCGCAAG-3 # . PCR reactions were performed with 33 cycles of denaturing at 95! !for 45 s, annealing at 57! !for 45 s, and extension at 72! !for 30 s. RT-PCR analysis was performed by three separate experiments under the same experimental conditions. Expression level of Rock1 mRNA was normalized to that of 18S rRNA.
Statistics
For the luciferase assay, data are mean "SD from at least two separate experiments with triplicate samples. For RT-PCR analysis, data are means "SD from three separate experiments (n = 3). Statistical analysis was performed by Student's t-test using Microsoft Excel 2010 software. A p value less than 0.05 was considered to be statistically significant.
RESULTS
Determination of Rock1 Transcription Start Sites (TSS)
Homology searches of human, mouse, and rat Rock1 cDNA in GenBank identified 5 # end structures with 84% and 96% homology to human and mouse sequences, respectively, compared with rat sequence (Fig. 1A) . However, TSS of rat Rock1 has not been identified yet. Therefore, we first performed RLM-RACE to define TSS after removing the 5 # -cap structures from intact full-length mRNA using tobacco acid pyrophosphatase. RLM-RACE products were then subcloned into the pGEM-T easy vectors. Based on sequence analyses of 11 randomly picked clones, we identified multiple potential TSS and defined the most 5 # end position as +1 (Fig. 1B) . Sequencing data from this study have been deposited into GenBank sequence database (accession number : AB861944).
Detailed inspections of sequence data revealed that the rat Rock1 promoter does not contain TATA or CCAAT boxes, which is in agreement with a report stating that TATA-less promoters often show multiple TSS (12) . Recent bioinformatic analyses indicated that approximately 76% of human core promoters lack TATA-like elements, have high GC contents, and are enriched in SP1-binding sites.
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Moreover, TATA-less genes are frequently involved in basic "housekeeping" processes, such as protein biosynthesis, cell growth and/or maintenance, and intracellular transport (13) .
Sp6 Binds to the "A" Region and Positively Regulates Rock1 Promoter Activity
Searches for potential Sp6-binding sites using TFBIND algorithm on the Rock1 promoter revealed multiple potential SP1 sites and GC-boxes at around 2,500-bp upstream of TSS. Subsequent in silico analyses using GENETYX software also identified five SP1-binding sites and one GC-boxes within 249-bp upstream region of TSS, which overlapped with TFBIND algorithm finding. Since we did not find any other sites within 2,500 bp of promoter region by GENETYX software, we focused on this 249-bp region, named as "A" (Fig. 2A) . To define regulatory regions of the Rock1 promoter, a series of reporter vectors were constructed with serial deletion of Rock1 5 ! -flanking promoter sequences by inserting at the upstream of the firefly luciferase coding sequence in the promoter-less plasmid vector, pGL3-basic (Fig. 2B ). Luciferase reporter assays were then performed to determine the effects of Sp6 on promoter activity. The Luc#4 reporter construct, which lacked the "A" region, exhibited no significant promoter activity or enhancement. In contrast, Luc#1, Luc#2, and Luc#3 constructs exhibited higher luciferase activities and were enhanced 1.5-fold by co-transfection with Sp6 expression plasmids compared with the control vector (Fig. 2B) indicating that the "A" region is required for basal activity and enhancement by Sp6.
To confirm Sp6 binding to the Rock1 promoter region, we performed ChIP assays using Sp6-stable transformant, C9 cells, and anti-HA antibody to precipitate HA-tagged Sp6 protein followed by PCR using specific primers for the "A" region. The predicted 266 bp-band of PCR products was detected, suggesting the specific binding of Sp6 to the "A" region (Fig. 2C) . Subsequent analyses of endogenous Rock1 mRNA expression in G5 cells with transient transfection of Sp6 expression vector were correlated significantly with Sp6-mediated promoter activity (p!0.001, Fig. 2D ).
Sp6 is Functionally Distinct from Sp1
To determine Sp6-binding sites within the "A" region, we dissected the overlapped SP1 sites and GCboxes as shown in Fig. 2A , into several reporter constructs (Fig. 3A, Luc#3 .1-Luc#3.5), and transiently cotransfected those reporter constructs and Sp6 or Sp1 expression vector into G5 cells. Luc #3 and Luc#3.1 demonstrated the enhancement of promoter activity by Sp6 at the similar level, however, deletion of the promoter region from -206 to -150 in Luc#3.2 (Fig. 3B) . Since Sp1 binding site is located in this region, it is possible that Sp6 may compete with Sp1 for binding this region. Indeed, both Sp1 and Sp6 mRNA are endogenously expressed in G5 cells (data not shown). To assess the effects of Sp1 on these promoter activities, we co-transfected with Sp1 expression vector and reporter plasmids. As shown in Fig. 3C , Sp1 suppressed Rock1 promoter activity with any length of promoter, suggesting that Sp6 is functionally distinct from Sp1. These results indicated that Sp6 and Sp1 may positively and negatively regulate Rock1 promoter activity, respectively. In addition, we observed the basal activity of Rock1 promoter in Luc#3.5.
Furthermore, we determined whether mithramycin A, a compound that interferes with Sp1 binding to GC-rich DNA sequences, affects Rock1 promoter activity directed by Sp1 or Sp6. Mithramycin A is frequently used to explore sequence specificities of DNA-binding factors, and its binding to GC-rich sequences prevents binding of regulatory proteins such as Sp1, resulting in inhibition of promoter-dependent transcription in vitro (14) . In our study, treatment with mithramycin A reduced the Sp6-mediated enhancement of Rock1 promoter activity in dose-dependent manner, especially up to 200 nM (Fig. 4A) . However, Rock1 promoter repression by Sp1 was not affected with mithramycin A (Fig. 4B) . As shown in Fig. 4C , Sp6-mediated enhancement of Rock1 expression was observed at the mRNA level and the enhancement was abolished in the presence of mithramycin A. However, in contrast, reduction of Rock1 expression by Sp1 was not observed at mRNA level and the Rock1 expression was not affected by mithramycin A treatment.
Determination of Sp6 Responsive Elements
The finding that mithramycin A inhibited the effects of Sp6 enhancement on the Rock1 promoter activity with the reporter constructs containing the region from -206 to -150, prompted us to further confirm Sp6 responsive elements within this region. Therefore, we performed ChIP assays in G5 cells using anti-HA antibody to precipitate HA-tagged Sp6 protein and followed by PCR using specific primers for the region -206 to -150. The specific binding of Sp6 to the Rock1 promoter region -206 to -150 was observed as the predicted PCR products (Fig. 5A) .
To ensure this result, we mutated the potential SP1 sites that were identified using GENETYX software for in silico analyses (Fig. 5B) . We also mutated AP2 sites, because AP2 site is GC-rich and the region from -206 to -150 contains two potential AP2 sites, which may be occupied by Sp6. In addition to the mutations in SP1 and AP2 sites identified by in silico analyses, we mutated 5 ! -GGGTTTCCG-3 ! in position number 1 (Fig. 5C ) because GGG is a putative DNA-binding site for Sp1 zinc finger 3 (15) . CCG is the complement sequence of CGG, which is possibly recognized by Sp1, because mutation of the 5 ! -GCGGGAGG-3 ! motif in the IER3 promoter markedly reduces basal and abrogated vorinostatinduced promoter activity (16) . Hence, we have referred to 5 ! -GGGTTTCCG-3 ! as a putative SP1-binding site.
As shown in Fig. 5C , mutation of putative SP1-binding site (Luc#3-mut 1) significantly reduced Sp6-mediated enhancement of Rock1 promoter activity( p!0.001), whereas mutation of two AP2 sites, Luc#3-mut-2 and Luc#3-mut-3 constructs, had no effect on the luciferase activity. Of interest, while mutation of SP1 site significantly increased basal activity (p!0.0001), Sp6 overexpression had no effect on promoter activity (Fig. 5C, Luc#3-mut 4) .
Next, we found the functional linkage between Sp6-enhancing effect on Rock1 promoter activity and Sp6 binding to each mutant construct by ChIP-PCR analyses (Fig. 5D) . We observed that Sp6 could bind to the Luc#3 reporter constructs with mutated AP2 sites (mut 2 and mut 3) but not with mutated putative SP1 and SP1 sites (mut 1 and mut 4). These data suggested that two sites containing GGGtttCCG and CGCCCG motifs in Rock1 promoter region -206 to -150 are critical for the Sp6-enhanced expression of Rock1. Therefore, Sp6 may have binding selectivity to GC-rich sequences. In addition, there is another possibility of Sp6 effect to Rock1 promoter activity ; the unknown molecule(s) could bind to AT-rich sequence of mut1, and recruit Sp6 through protein-protein interaction, resulting in enhancement of the promoter activity. However, further investigation is necessary to explain the underlying mechanism.
DISCUSSION
The present study explored the regulatory mechanisms of Rock1 promoter activity by Sp6, and demonstrated that Sp6 could bind directly to the proximal 249-bp region of the Rock1 promoter and enhanced basal promoter activity. This is the first report to characterize the effect of Sp6 on Rock1 promoter regulation with its different role from another Sp family member, Sp1.
Distinct regulation by Sp family members is a quite interesting issue in terms of cell-and tissuespecificity (17) . Nine members in Sp family have been identified with conserved three zinc finger DNA binding domains at C-terminus. In addition, Sp1-4 proteins contain long N-terminal regulatory domains, but Sp5-9 proteins have shorter N-terminus domains (17, 18) . These structural differences may explain a part of the distinct regulatory function. Functional promoter analysis using luciferase reporter assay indicated that over-expression of Sp6 in G5 cells enhanced Rock1 promoter activity and endogenous Rock1 mRNA expression (Fig. 2D and  Fig. 4C ). However, we observed suppression of Rock1 promoter activity in the presence of Sp1 (Fig.  3B) , and this suppressive effect did not correlate with endogenous Rock1 mRNA expression (Fig.  4C) . Indeed, we only examined the effect of Sp1 on the "A" region of the Rock1 promoter by in vitro system. It remains unclear whether other regions in Rock1 promoter are involved in Sp1-mediated endogenous promoter activity. Furthermore, we can measure the steady-state levels of mRNA by RT-PCR analysis, which are regulated at the transcriptional level and stability in a post-transcriptional manner (19) . The mRNA stability is regulated by the interaction between cis-acting, i.e. sequence and structures, and trans-acting factors, i.e. alternative splicing regulatory factors, turnover and translation regulator RNA-binding proteins, and non-coding RNAs (20) . It is possible that the post-transcriptional regulator(s) could maintain endogenous Rock1 mRNA level against Sp1-mediated suppression.
Furthermore, we observed that mithramycin A treatment interfered Sp6-, but not Sp1-mediated Rock1 promoter activity. These findings did not show the direct evidence of Sp1-or Sp6-binding to GC-rich DNA elements on Rock1 promoter region, but they clearly demonstrated that Sp6-mediated regulation of Rock1 transcription relies on GC-rich DNA sequence. It suggested that Sp1 has different regulatory mechanisms from Sp6, possibly through the protein-protein interaction with other transcription factor(s). This hypothesis may explain that mutated-putative SP1 site did not show any elevation of basal activity in Figure 5C .
Mutation analysis of Rock1 promoter elements revealed additional interesting findings ; mutation of known SP1 and putative SP1 sites abolished Sp6-mediated enhancement of Rock1 promoter activity and increased basal activity in Luc#3-mut4 construct, respectively (Fig. 5C ). The latter finding raised a question for the underlying mechanisms.
Since we found Sp1 has suppressive effect in Rock1 promoter, the increased basal activity may simply occur by abolished endogenous Sp1 binding. However, we also have to consider the involvement of other molecules. We observed transient Ap2-overexpression suppressed Rock1 promoter activity (data not shown). Ap2 has been shown to bind to not only the authentic sequence motif 5 ! -GCCN3GGC-3 ! , but also to the different motifs such as 5 ! -CCCCAGGC-3 ! in the SV40 enhancer element and E-box site 5 ! -CACGTG-3 ! in the Myc-response element (21, 22) . Therefore, Ap2 might bind to the region containing Sp1 site 5 ! -CGCCCG-3 ! to suppress promoter activity.
In addition, mutation of SP1 sites might abolish the suppressive effects of transcriptional repressor GC-factor (GCF), because the GCF-binding motif 5 ! -GCCCCGC-3 ! was indicated in the Rock1 promoter region from the region of -162 to -156 overlaps with AP2-and SP1-binding sites by in silico analysis (Fig. 5B) . GCF was originally isolated as a factor that binds to GC-rich sequences (GCGGG-GC) and represses transcription of epidermal growth factor receptor (EGFR ), β-actin, and calcium-dependent protease promoters (23) .
The biological role of Sp6-Rock1 axis could be suggested by their expression patterns and functions. Immunohistochemical analyses demonstrated that Sp6 and ROCK1 express sequentially (3, 9) . Cytosolic ROCK1 were detected at low level in basal epithelial cells, inner enamel epithelium cells, and presecretory ameloblasts (9) . Moreover, ROCK1 was strongly expressed in secretory and mature ameloblasts (9) , following the Sp6 expression in the nuclei of presecretory and secretory ameloblasts (3). On the other hand, the Rho family inhibitor RhoGDI was downregulated during ameloblast secretory stage (24) . Interestingly, expression of RhoA, the direct upstream activator of ROCK, and ROCK1 were also detected strongly in highly polarized ameloblasts, but weakly in non-polarized cells of inner epithelium and dental papilla during tooth development (9, 10) .
Rock1 plays pivotal roles in epithelial cell polarity by regulating PAR-1b activity and restricting basement membrane position (25) , supporting that ROCK1 contributes to the polarity, proliferation, and differentiation of ameloblasts (9) . In agreement with this, we found that Sp6 regulates ameloblast morphology and polarity by restoring polarization, alignment, and height of ameloblasts in Ami/Ami Tg rats with an Sp6 transgene (5). Taken together, our findings suggested that Sp6 plays an important role in amelogenesis by regulating Rock1 expression, which involved in ameloblasts morphology and polarity. Further analyses are required to investigate the role of Sp6 as a transcription factor during tooth development and develop the in vivo system for tooth regeneration.
